These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20391588)

  • 1. Benefit-risk analysis for the clinician: 'primum non nocere' revisited--the case for antipsychotics in the treatment of behavioural disturbances in dementia.
    Naarding P; van Grevenstein M; Beekman AT
    Int J Geriatr Psychiatry; 2010 May; 25(5):437-40. PubMed ID: 20391588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antipsychotics against anxiety in dementia: medical treatment or chemical restraints?].
    Ruths S; Straand J
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1672-5. PubMed ID: 15976839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
    Ballard CG; Margallo-Lana ML
    J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifteen year comparison of antipsychotic use in people with dementia within hospital and nursing home settings: sequential cross-sectional study.
    Connelly PJ; Law E; Angus S; Prentice N
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):160-5. PubMed ID: 19513989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How psychiatrists inform themselves and their patients about risks and benefits of antipsychotic treatment.
    Mendel R; Hamann J; Traut-Mattausch E; Jonas E; Heres S; Frey D; Kissling W
    Acta Psychiatr Scand; 2009 Aug; 120(2):112-9. PubMed ID: 19236315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elderly safety imperative and antipsychotic usage.
    Chahine LM; Acar D; Chemali Z
    Harv Rev Psychiatry; 2010; 18(3):158-72. PubMed ID: 20415632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
    [No Abstract]   [Full Text] [Related]  

  • 12. How safe are antipsychotics in dementia?
    BMJ Group
    Drug Ther Bull; 2007 Nov; 45(11):81-5. PubMed ID: 18165678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: a Roadmap.
    Weiden PJ; Preskorn SH; Fahnestock PA; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2007; 68 Suppl 7():1-48. PubMed ID: 17650057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics in the management of behavioral symptoms associated with dementia.
    González-Concepción JJ; Geil K; Jiménez-Velázquez IZ; Ramos-Romey C
    Bol Asoc Med P R; 2009; 101(1):51-3. PubMed ID: 19954089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia.
    Jeste DV; Meeks T
    South Med J; 2007 Oct; 100(10):961-3. PubMed ID: 17943030
    [No Abstract]   [Full Text] [Related]  

  • 16. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: a hospital-based, retrospective, cohort study.
    Chan MC; Chong CS; Wu AY; Wong KC; Dunn EL; Tang OW; Chan WF
    Int J Geriatr Psychiatry; 2010 Apr; 25(4):362-70. PubMed ID: 19650162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics.
    Phillipson M; Moranville JT; Jeste DV; Harris MJ
    Clin Geriatr Med; 1990 May; 6(2):411-22. PubMed ID: 1970512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of medications in treating the behavioural disturbances of dementia sufferers.
    Jackson LD
    Perspectives; 1995; 19(3):9-22. PubMed ID: 7572001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.